Background. Engaging patients across the research trajectory supports research that is generalizable, high quality, timely and actionable. However, this approach comes with challenges and opportunities as investigators and engaged patient stakeholders encounter institutional policies around patient engagement, privacy and research participant protection. Objective. To describe the resolution and impact of quandaries arising when patient stakeholders' values and preferences conflicted with institutional policies. Methods. Case study from a Patient-Centered Outcomes Research Institute-funded trial. Results. The first example focuses on the tension between the health care organization's requirements for background checks for all patient advisors and the funders' requirement to engage hard-to-reach populations. To create an environment of mutual trust and respect with patient stakeholders, the research team decided against imposing background checks. All 53 patient and parent advisors have served continuously for 2 years and meeting attendance exceeds 95%. The second example describes parent stakeholders' role in revising a letter informing patients about a privacy violation. Among 49 families affected by and informed about this violation, 35 (71%) agreed to participate. The third example focuses on how patient stakeholder preferences about study reminders conflict with the 1996 Health Insurance Portability and Accountability Act rules. While patient stakeholders strongly endorsed text message reminders, regulations and technology do not permit reminders with enough detail to ensure clarity. Although retention rates exceeded 90%, attendance at study appointments was below 75% and below 60% for minority and low socio-economic status families. Conclusion. Patient engagement positively impacts research. Resolving conflicts between patientengaged research and existing institutional policies and regulations would allow this impact to become fully realized.
Introduction
Patient-centred outcomes research (PCOR) has opened a new opportunity for patients to influence innovation in health care by going beyond their more commonplace roles as research participants or advisors to health care systems (1) . Ongoing engagement of patient stakeholders across the research trajectory is at the heart of PCOR.
More broadly, there has been a call for patient engagement in quality improvement and safety initiatives over the last decade (2) . In response, many health care organizations now include patients on Patient and Family Advisory Councils (PFACs) or similar groups to advise them on topics such as design and marketing of new facilities or services, prioritizing new programmes or quality improvement (3) . As such, PFACs were created to advance the success of the health care entity and they have in-place policies and procedures designed to meet that goal.
Championed in the USA by the Patient-Centered Outcomes Research Institute (PCORI), PCOR has enhanced traditional health research, ensuring that the topic and the outcomes assessed are meaningful for patients broadly. To achieve this, PCORI-funded research engages patients across the life of the research project (1) . This often includes patient stakeholder engagement at the very early stages of research, prior to the submission of an application, when funding for patient engagement is limited or non-existent. Thus, for researchers in academic medical centres wishing to compete for PCORI funding, the parent health care entity's PFACs are a logical place to obtain early, low-cost patient feedback to shape a research proposal and demonstrate patient stakeholder interest. However, policies created specifically to govern PFACs may conflict with the goals of PCOR, creating challenges and opportunities to further engaging patients as stakeholders in research to improve health and health care.
In PCOR, challenges in the application of traditional policies to protect research participants also arise, as the role of stakeholders in research extends far beyond the previous model of patients as passive human subjects. PCORI has specifically encouraged high-level stakeholder engagement, with the pinnacle being stakeholders who are full-fledged members of the research team. In academic medical centres, federal law requires researchers to rely on institutional review boards (IRBs) to provide guidance to protect research participants (4), with existing policies often created to oversee research at a time before patient stakeholder engagement had become an established practice. Further, educational institutions and health care entities associated with these medical centres have privacy officers charged with implementing privacy policies and procedures. As a result, the mandates guiding IRBs and institutional privacy officers may naturally conflict with the goals of researchers and PCOR champions. Thus, conducting research with this new approach presents challenges and opportunities as PCOR investigators and their engaged patient stakeholders encounter long-standing legal regulations and institutional policies around the protection of research participants.
Methods
This paper presents three examples of tensions between the values and preferences of patient stakeholders and institutional policies in an ongoing, PCORI-funded randomized control trial. Project ACE (Achieving control, Connecting resources, Empowering families) is using sustained and intensive stakeholder engagement in a multisite trial that evaluates the impact of tailored self-management resources on blood sugar control and quality of life for youth with type 1 diabetes. The trial compares a group receiving usual care with a group that receives four group-based intervention session tailored to meet the participant's specific self-management barriers. Delivering the intervention sessions and collecting data without disrupting routine health care delivery for either patients or clinic staff required complex logistics. To inform the conduct of PCOR in the context of academic medical centres and health care delivery systems, this paper presents three examples from this PCORI-funded trial in which the values and preferences of patient stakeholders conflicted with institutional policies, discussing the role of patient stakeholders in resolving these conflicts and the impact on the study's success.
Results

PFAC-mandated background checks
In the early stages of this research, investigators sought to engage youth with type 1 diabetes and their parents in designing and conducting a trial of family-centred diabetes self-management resources. At the time the proposal was submitted, the researchers envisioned working with leadership from the children's hospital's PFAC, securing a support letter from the director and budgeting to support their assistance with facilitating engagement of these families. Upon funding, discussions between the researchers and PFAC leadership were fruitful, resulting in offers to assist in identifying families who would commit to advising a 3-year research project and to consult on preparing families and researchers for their interactions.
Although partnering with the PFAC seemed advantageous, PFACmandated background checks for advisors created an unexpected hurdle. A key tenet of the PCORI approach to making research meaningful is to involve 'hard-to-reach' populations, i.e. being inclusive of people from diverse backgrounds and experiences, across all races, social economics and other relevant factors (5, 6) . PFAC leadership and institutional attorneys, however, as part of their standard onboarding process required a background check for any adult wishing to join the PFAC. They deemed background checks necessary to protect child patients from harm by criminals such as pedophiles. Further, as PFAC members were sometimes privy to business plans or other sensitive information, the checks were believed to limit potential damage by advisors tempted to use or reveal such information for personal gain. To host stakeholder meetings at the clinic, which was a familiar and an accessible space for the stakeholder families, background checks would have been necessary for all parents.
Concern arose that individuals from hard-to-reach populations who wanted to advise our research could be dissuaded by requiring background checks. The notion of background checks is often coupled with negative connotations of mistrust and judgement. In addition, such checks can be perceived as invasive, creating a sense of unfairness in a selection process (7, 8) . In turn, these feelings can lead to refusal to accept a position, higher likelihood of leaving a position and less engagement in the role (9, 10) .
Because selection procedures are perceived as more fair and acceptable when their rationale is explained (10), the research team tried to develop language to explain the purpose and exact content of these background checks. During this process, it became unclear exactly what information would be reported with these background checks. There was concern that potential advisors would have irrelevant yet potentially embarrassing infractions like parking or speeding tickets disclosed to PFAC leadership. Given that the goal of engaging these stakeholders was to gather advice and feedback about the research, advisors would have no direct patient contact and no access to any individual patient health information. In this light, the purpose and value of such disclosures were difficult to rationally explain to potential stakeholders. As a result, the research team ultimately revised their approach to stakeholder engagement in favour of creating an environment of mutual trust and respect with the youth and parents who served on the project advisory board. Alternative, non-clinic locations were used as meeting places, which allowed for a diverse group of people to join the advisory boards. In seven meetings for >2 years with 53 parents and youths, no issues have arisen with personal safety or disclosure of sensitive information. Attendance exceeded 95%.
Engagement of parent stakeholders in remediating a privacy breach
In August 2014, a research team member sent an email to 106 parents of potential research participants, inviting them to the study. These families had previously provided written consent to be contacted for future research. The research team member who sent the email inadvertently included the list of recipient email addresses in the 'To' rather than the 'BCC' line, thus exposing all recipients to other patients' diagnoses and contact information. About 5 minutes after the email was sent, the research team member realized this error and immediately notified the principal investigator (PI). The PI then notified IRB leadership, the campus privacy officer, the department chair and the patients' providers. Two parents also reported the error to the research team, one by phone and another via email. Neither of them withdrew from future contact.
Because the campus privacy officer was not available immediately, IRB leadership and research team members worked together to respond swiftly with the goal of mitigating any potential harm from this error. The research team crafted an apology email, which included a request that families help limit any potential harm by deleting the prior email. This email was approved by IRB leadership and sent to all recipients within 24 hours. Twelve days later, the campus privacy officer emailed the PI, requesting information about the error. Ultimately, the officer determined that a notification of the privacy breach would need to be mailed to each family to meet legal requirements.
The project's parent advisory board then played a key role in shaping the institution's response to this privacy breach. An initial draft of the notification letter written by the university privacy officer was provided to the PI for review at her request (Figure 1 ). This draft was revised based on feedback from the study's parent advisory board as follows:
1 Parents thought the language should refer specifically to the researchers, instead of using pronouns such as 'we', so that parents understood clearly who was responsible for the error and that their doctors were not responsible. 2. Parents preferred language that referenced actions to reduce the likelihood that such an error would happen again, rather than suggesting actions could entirely prevent similar incidents. 3. Parents were extremely empathetic towards the research team's circumstances and voiced how they themselves had made similar errors in the past. The advisory group members voiced their understanding that the mistake was due to human error, not ill will.
The privacy officer ultimately incorporated only the third suggestion into the letter mailed to those affected by the breach. Specifically, the language referring to disciplinary action towards the employee was removed (highlighted in Figure 1 ). After the apology email and mailed letter were sent, recruitment for the study started. During in-clinic recruitment, research team members encountered 49 of the 106 families who had been affected by the breach. Of these families, 35 (71%) consented to participate in the trial. Further, while the study team feared that the email error would be raised by families in clinic, this did not happen.
Family preferences for reminder contact and privacy regulations
To maximize attendance at study activities and usual care appointments, the researchers sought advice from patient and parent stakeholders about the content, format and timing of study reminders. Parents and youth strongly preferred text message reminders for an upcoming clinic visit or study activity, as opposed to postal mail or email. Stakeholders also advised that the text should be specific and include date and time of the study activity or appointment. Having families arrive in clinic at the correct time for their appointments was critically important to maintaining clinic support and retaining families in the study.
The 1996 Health Insurance Portability and Accountability Act (HIPAA) regulates and restricts how US health care organizations and their affiliates can share protected health information (PHI) through electronic means. To comply with HIPAA regulations, experts recommend either completely excluding PHI from text messages or complying with the HIPAA security rule (11) . Because our study activities were integrated into routine clinical care, text messages would need to include several PHI elements to avoid confusion with the timing of clinic appointments. Following available guidance, any reference to a condition or to the time of a health care appointment more specific than a year is considered PHI. Thus, the research team could not include the word 'diabetes' when referring to the appointment nor include even the date of an upcoming appointment, let alone the appointment time. These limitations would have rendered text message reminders virtually useless, possibly even creating more confusion and frustration for participating families and clinic staff. For these reasons, the research team eventually decided to abandon text reminders and sent reminders by email or postal mail.
While retention of study families and online survey data collection of 6-month follow-up has exceeded 90%, attendance at study intervention sessions was only 72% (304 of 423 potential sessions attended). Further, attendance at intervention sessions was only 56% (37 of 68 potential sessions attended) among minority families and 56% (54 of 96 potential sessions attended) among families with a high school education or less. 
Discussion
These examples from this PCORI-funded trial illustrate some of the opportunities and challenges presented by engagement of patient stakeholders in research. In general, there is an air of hopefulness as patients are invited to mould the research enterprise towards high-quality, actionable, timely investigations that are meaningful to the very people whose lives may benefit. As this cultural change washes over the field and brushes up against the existing landscape of institutional policies created over many decades, growing pains are to be expected.
Despite the enthusiasm of PFACs to engage in guiding research activities and supporting investigators, in reality, misalignment of goals and limited PFAC resources make this a less than sustainable solution. PFACs primarily focus on health care delivery, helping hospitals improve patient experiences, patient safety and quality of care, with the end goal being favourable public reporting of these measures and ultimately financial rewards and greater market share (12) . Engagement in research, on the other hand, is usually not part of the mission of PFACs. As in our own experience with background checks, these divergent goals may not align well with the PCOR ideal of including hard-to-reach populations as advisors. To foster meaningful engagement of representative groups of patients, PFACs need resources and infrastructure that support ongoing and deep engagement, especially of those patients whose voices are seldom heard and for whom disparities in outcomes of care continue unabated (13) . Although over one-third of hospitals now have PFACs in place, a recent survey found that over half of these PFACs had not met in the last year (3). Competing organizational priorities and time and effort requirements create significant barriers to patient engagement for 30-50% of hospitals. Without greater resources, PFACs are unlikely to become a sustainable and accessible source to engage patient stakeholders, especially those from hard-to-reach populations.
In making recommendations for effective patient engagement, the Institute for Patient and Family-Centered Care has acknowledged that attitudinal barriers in particular were a driving force in limiting the intensity and potential benefits of patient engagement (13) . Concern that PFAC members might compromise patient confidentiality as well as fears that some patients are too violent, poor or uneducated to be PFAC members have thwarted efforts to engage patients, especially those from racial/ethnic minorities or lower socio-economic groups (13) . Just as health care entities may 'mistrust' these patients, these patients were also more likely to mistrust health care and health research (3, 13, 14) . A policy of gradual, supported engagement may foster trusting relationships that allow PFACs to benefit from the perspectives of these hard-to-reach populations. Also, gradual engagement could render background checks obsolete, replacing feelings of mistrust with relationships of mutual respect and understanding.
Although text messaging can improve appointment attendance (15) and was preferred by our participants and stakeholders, policies intended to protect patients and research participants limit this tool from realizing its full potential. Text messaging is widely available, with 90% of US adults having a cell phone in 2013 and 81% of owners using their phone to send or receive text messages (16). These numbers are comparable among hard-to-reach populations (16). The use of text messages in health research in the USA is governed both by federal law (especially HIPAA) and locally through oversight by IRBs. However, there are contradictory interpretations and a lack of guidance for researchers regarding what is and is not permitted when using text messages with research participants (11, 17) . Using the guidance available to us at the time, we concluded that any permissible text message would have been too vague to be useful. Popular, consumer-oriented messaging apps such as WhatsApp have integrated encryption into their platforms and services, which may provide a technological solution to the problem. But this necessitates a user having a smartphone and installing the app, as opposed to the almost universal availability of text messaging. Further, even with encryption in place, it remains uncertain whether sending messages containing PHI through these apps would indeed comply with HIPAA regulations (e.g. the requirement that the message is secure throughout the transmission chain from sender to receiver) (18) . In our study, the ability to send text message reminders with study appointment date and time may have improved intervention completion, enhancing the generalizability of our findings.
The ability of our parent advisors to make very reasonable and actionable suggestions for institutional language about unintended errors raises the issue of whether entities that interface between patients and researchers should always include patient advisors in their work. Although technology has accelerated to support immediate and low effort mass communication, human error persists. In fact, errors similar to our email disclosure of PHI occurred recently in London when the names and email addresses of 780 patients who sought services at an HIV and sexual health clinic were visible when the clinic emailed its newsletter (19) . Our patient advisors were savvy in recognizing that a letter claiming that these types of errors could be prevented in the future was not credible and that the letter needed to clearly state who was taking responsibility for the error. Further, they understood that human error, and not malfeasance, caused the unintended disclosure, making the privacy officer's statement about disciplinary action for the employee appear misguided.
Conclusion
As evidence of the value of patient engagement mounts, health care entities and researchers are rapidly assimilating these perspectives through various processes. This benefit does not come without challenges and increased resource costs. Effort is needed to prioritize addressing these challenges and to develop policies and systems that are nimble in their response to this swiftly changing environment. Engaging patients at all levels and phases of research, including study design, execution, analysis and dissemination, is crucial to successful PCOR. Going one step further, patient engagement at the regulatory level, e.g. as IRB members (20) or as advisors to lawmakers and regulatory bodies such as FDA may also resolve some of the tensions laid out in this paper. Further, the three examples of quandaries in our own research that we have described undoubtedly are challenges that are context specific. In the USA, current policies, procedures and funding mechanisms around patient engagement might need to revisited and modified to pave the way towards fully engaging patient stakeholders in research. Regardless of national or institutional context, willing and progressive partnerships between researchers, regulators, health care delivery systems and others involved in our research processes are crucial to achieving this goal. 
